GSK plc: Statement re. Zantac (ranitidine) Litigation
Henry Boot plc Agrees Sale of Strategic Land Site in Oxfordshire
B.P.Marsh & Partners plc Announce Share Buy-Back Programme
B.P.Marsh & Partners plc Final Results for the Year Ended January 2024
GSK plc- FDA Approves Arexvy for Adults Aged 50-59 at Risk
TR Property Annual Results for the Year Ended 31st March 2024
Templeton Emerging Markets Investment Trust plc Annual Report and Accounts to March 2024
